FDA Approved: ETODOLAC — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

FDA approved a supplemental application for Etodolac submitted by Taro Pharmaceuticals U.S.A., Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Etodolac (Etodolac)

Snippet

SUPPL AP for ETODOLAC (ETODOLAC)